uniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapykatie8288Jun 23, 20220 min read
Looking Forward Together: An Open Letter from the Huntington's Disease Advocacy Community to the White House
Comments